New pill for sleepiness? early human testing begins
NCT ID NCT07082829
First seen Jan 11, 2026 · Last updated May 01, 2026 · Updated 21 times
Summary
This early-stage study tests a new drug called ORX142 in healthy adults and older adults to see if it is safe and how the body processes it. Some participants will be kept awake overnight to see if the drug helps with alertness. The goal is to gather safety information before testing in people with excessive daytime sleepiness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXCESSIVE DAYTIME SLEEPINESS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Site #1
RECRUITINGLincoln, Nebraska, 68502, United States
-
Site #2
RECRUITINGEatontown, New Jersey, 07724, United States
-
Site #3
RECRUITINGNew York, New York, 10019, United States
Conditions
Explore the condition pages connected to this study.